![]() |
Home
| Databases
| WorldLII
| Search
| Feedback
Australian Parliamentary Joint Committee on Human Rights |
3.1 The committee has deferred its consideration of the following legislation for the reporting period:
• National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 10) [F2021L01485];
• National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021 (No. 10) [F2021L01487];
• National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (November Update) Instrument 2021 [F2021L01488];
• National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 10) [F2021L01489];
• National Health (Listed Drugs on F1 or F2) Amendment Determination 2021 (No. 8) [F2021L01491]; and
• National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 9) [F2021L01493].
[1] This appendix can be cited as: Parliamentary Joint Committee on Human Rights, Deferred legislation, Report 14 of 2021; [2021] AUPJCHR 144.
AustLII:
Copyright Policy
|
Disclaimers
|
Privacy Policy
|
Feedback
URL: http://www.austlii.edu.au/au/other/AUPJCHR/2021/144.html